US Bancorp’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.45M Buy
16,047
+847
+6% +$475K 0.01% 478
2026
Q1
$8.54M Sell
15,200
-302
-2% -$194K 0.01% 447
2025
Q4
$10.5M Buy
15,502
+243
+2% +$165K 0.01% 425
2025
Q3
$9.75M Buy
15,259
+144
+1% +$87.4K 0.01% 439
2025
Q2
$8.11M Sell
15,115
-1,072
-7% -$513K 0.01% 463
2025
Q1
$6.8M Sell
16,187
-432
-3% -$188K 0.01% 504
2024
Q4
$6.87M Sell
16,619
-1,545
-9% -$678K 0.01% 500
2024
Q3
$9.18M Sell
18,164
-233
-1% -$113K 0.01% 448
2024
Q2
$8.96M Sell
18,397
-542
-3% -$272K 0.01% 439
2024
Q1
$10.2M Sell
18,939
-881
-4% -$481K 0.01% 421
2023
Q4
$11M Buy
19,820
+502
+3% +$236K 0.02% 406
2023
Q3
$8.45M Buy
19,318
+76
+0.4% +$37.9K 0.01% 430
2023
Q2
$9.66M Sell
19,242
-16,388
-46% -$7.85M 0.02% 418
2023
Q1
$17.8M Sell
35,630
-1,508
-4% -$722K 0.03% 304
2022
Q4
$15.2M Sell
37,138
-1,544
-4% -$599K 0.03% 333
2022
Q3
$12.6M Sell
38,682
-1,607
-4% -$590K 0.03% 330
2022
Q2
$14.1M Sell
40,289
-6,634
-14% -$2.71M 0.03% 321
2022
Q1
$25.7M Buy
46,923
+815
+2% +$429K 0.04% 247
2021
Q4
$30.4M Buy
46,108
+415
+0.9% +$261K 0.05% 232
2021
Q3
$28.4M Buy
45,693
+832
+2% +$559K 0.05% 229
2021
Q2
$28.3M Buy
44,861
+304
+0.7% +$168K 0.05% 236
2021
Q1
$21.8M Buy
44,557
+202
+0.5% +$101K 0.04% 263
2020
Q4
$22.2M Buy
44,355
+3,768
+9% +$1.69M 0.05% 250
2020
Q3
$16M Buy
40,587
+9,050
+29% +$3.35M 0.04% 286
2020
Q2
$10.4M Buy
31,537
+14,005
+80% +$4.05M 0.03% 349
2020
Q1
$4.25M Buy
17,532
+1,892
+12% +$494K 0.01% 468
2019
Q4
$4.08M Buy
15,640
+1,214
+8% +$320K 0.01% 571
2019
Q3
$3.92M Buy
14,426
+2,189
+18% +$609K 0.01% 561
2019
Q2
$3.37M Sell
12,237
-16
-0.1% -$3.94K 0.01% 611
2019
Q1
$2.74M Buy
12,253
+48
+0.4% +$9.91K 0.01% 662
2018
Q4
$2.27M Buy
12,205
+656
+6% +$134K 0.01% 686
2018
Q3
$2.88M Sell
11,549
-27
-0.2% -$6.55K 0.01% 677
2018
Q2
$2.52M Sell
11,576
-597
-5% -$123K 0.01% 709
2018
Q1
$2.33M Sell
12,173
-344
-3% -$63.5K 0.01% 741
2017
Q4
$1.96M Sell
12,517
-1,088
-8% -$171K 0.01% 802
2017
Q3
$2.12M Sell
13,605
-1,693
-11% -$268K 0.01% 769
2017
Q2
$2.47M Sell
15,298
-2,365
-13% -$384K 0.01% 685
2017
Q1
$2.73M Sell
17,663
-3,515
-17% -$485K 0.01% 656
2016
Q4
$2.48M Sell
21,178
-2,640
-11% -$301K 0.01% 675
2016
Q3
$2.69M Sell
23,818
-10,779
-31% -$1.14M 0.01% 629
2016
Q2
$3.21M Sell
34,597
-6,931
-17% -$595K 0.01% 562
2016
Q1
$3.25M Buy
41,528
+2,413
+6% +$174K 0.01% 551
2015
Q4
$2.85M Buy
39,115
+2,612
+7% +$186K 0.01% 596
2015
Q3
$2.71M Buy
36,503
+2,204
+6% +$158K 0.01% 608
2015
Q2
$2.2M Sell
34,299
-1,221
-3% -$84.5K 0.01% 692
2015
Q1
$2.74M Sell
35,520
-738
-2% -$57.4K 0.01% 622
2014
Q4
$2.69M Sell
36,258
-2,536
-7% -$178K 0.01% 616
2014
Q3
$2.29M Buy
38,794
+3,708
+11% +$234K 0.01% 646
2014
Q2
$2.34M Sell
35,086
-202
-0.6% -$12.8K 0.01% 647
2014
Q1
$2.14M Buy
35,288
+4,916
+16% +$293K 0.01% 672
2013
Q4
$1.61M Buy
30,372
+1,714
+6% +$90.2K 0.01% 732
2013
Q3
$1.43M Buy
28,658
+1,442
+5% +$69.3K 0.01% 759
2013
Q2
$1.22M Buy
+27,216
New +$1.19M 0.01% 788

Other funds holding IDXX

US Bancorp's IDXX Position: Q2 2026 in Review

US Bancorp increased its Idexx Laboratories (IDXX) stake by 5.6% in Q2 2026, buying an estimated $475K and bringing the position to 16,047 shares worth $8.45M. The position accounts for 0.01% of the portfolio, ranked #478.

US Bancorp first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $30.4M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • US Bancorp held 16,047 shares of Idexx Laboratories worth $8.45M as of Q2 2026.
  • US Bancorp bought 847 Idexx Laboratories shares in Q2 2026, an estimated $475K.
  • Idexx Laboratories made up 0.01% of US Bancorp's portfolio in Q2 2026, its #478 holding.
  • US Bancorp first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's Idexx Laboratories position peaked at $30.4M in Q4 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.